Managing transplant patients: Treatment options expanding as solid organ transplants become more common

The Role of the Dermatologist in Management of Skin Disease in Solid Organ Transplant Recipients (S003)

As the number of solid organ transplant patients increases and their outcomes improve, dermatologists are treating more of them to manage skin diseases and cancers. A Friday symposium will discuss medical and surgical management options, chemoprevention, and new technologies, such as non-invasive imaging.

“This symposium is aimed at the general dermatologist who sees these transplant recipients and how to approach them,” said symposium director Nathalie C. Zeitouni, MD. “How often do we need to screen or biopsy them? What are the novel therapies?  How do we manage the more challenging conditions? When do we need to work in a multidisciplinary fashion?”

“The Role of the Dermatologist in Management of Skin Disease in Solid Organ Transplant Recipients” will feature three sections, with a question-and-answer session at the end of each section.

0303-transplantThe first part of the session will have four presentations addressing common skin conditions, psoriasis and biologics, treating pediatric patients, and the role of chemoprevention.

“Speakers will discuss nonmalignant and malignant conditions, patient awareness, and common and unusual diseases that we see in adult and pediatric transplants,” said Dr. Zeitouni, professor of dermatology at the University of Arizona College of Medicine, Phoenix. “They will also talk about chemoprevention measures we can use to help manage our patients before they develop many skin cancers.”

The second set of presentations will look at therapeutics, non-invasive therapy, topical agents for field therapy, future direction of treatment, the use of dermatologic surgery for transplant patients, and non-invasive imaging to assist in managing patients.

“There will be discussions on photodynamic, topical, and intralesional therapies,” Dr. Zeitouni said, adding that other options discussed will include confocal microscopy and the role of the Mohs surgeon. “The presentations will also look at when to refer patients to other specialists and what conditions to consider.”

The final part of the symposium will focus on rare tumors, as well as graft versus host disease, cutaneous lymphomas, and managing melanoma.

“There will be interesting updates on Merkel cell carcinoma in immunocompromised patients and on ocular tumors in transplant patients,” Dr. Zeitouni said.

Among the symposium topics that will be discussed are chemoprevention, optimizing field therapy, and the latest advances in managing skin cancers, she said.

“There are many new topics that we are going to cover,” Dr. Zeitouni said. “This is not just about skin cancer. The speakers will present new perspectives and interesting updates on what is going on in the field.”

Return to index

Top